Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG Split-Dose vs Single-Dose in Hospitalized Patients
NCT00626054Phase 4Completed
- Sponsor
- Rabin Medical Center
- Start
- Mar 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of macrogol in colorectal cancer (CRC) (2 arms), sponsored by Rabin Medical Center. Primary endpoints: Cleanliness of the bowel at 1 year and Ease of use and patient satisfaction at 1 year. Started Mar 2009; status: completed.
02
Drugs
macrogol
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00626054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626054.